FDA Investigator

Kerun Hardeo

Latest inspection on record: Nashik, India, May 2026 · records back to 2022

Human DrugsBiologicsMedical Devices & Rad HealthFoods & Cosmetics

FDA inspection record · Last updated July 12, 2026

Overview

  • 60 inspections across 59 sites are on record.
  • 36 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-22.

At a glance

Inspections

60

Sites

59

Observations

36

Career since

Jan 2022

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Dr. Mahesh G. Bhirud, M.D.22 May 2026Human DrugsOn file
Rajendra Sonde, M.B.B.S.9 May 2026Human Drugs
Alkem Laboratories Ltd., Bioequivalence Centre8 May 2026Human Drugs
Dr. Mitulkumar Manubhai Chaudhari, M.D.24 Apr 2026Human Drugs
Vennela Venkata Naidu, MBBS10 Apr 2026Human Drugs

Sites inspected

Dr. Mahesh G. Bhirud, M.D.Nashik, India1 insp.
Rajendra Sonde, M.B.B.S.Mumbai, India1 insp.
Alkem Laboratories Ltd., Bioequivalence CentreNavi Mumbai, India1 insp.
Dr. Mitulkumar Manubhai Chaudhari, M.D.Himatnagar, India1 insp.
Vennela Venkata Naidu, MBBSVisakhapatnam, India1 insp.

Co-investigators

Investigators who share inspections with this person.

Byungja E Marciante2 shared
Yuyan Liang2 shared
Simona M Bancos1 shared

Full investigator report

Get the verbatim findings behind Kerun Hardeo's 36 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators